Baxter International Inc.
BAX
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care productā¦ read more
Healthcare
Medical Instruments & Supplies
44 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$16.68
Price-0.60%
-$0.10
1Y
Price
Market Cap
$8.582b
Mid
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-15.0%
EBITDA Margin-37.9%
Net Profit Margin+14.9%
Free Cash Flow Margin-15.0%
EBITDA Margin-37.9%
Net Profit Margin+14.9%
Free Cash Flow MarginRevenue
$11.244b
+5.7%
1y CAGR+3.8%
3y CAGR-1.4%
5y CAGREarnings
-$957m
-47.5%
1y CAGR+12.4%
3y CAGR-63.1%
5y CAGREPS
-$1.75
-43.3%
1y CAGR+13.6%
3y CAGR-62.6%
5y CAGRBook Value
$6.102b
$20.055b
Assets$13.953b
Liabilities$10.003b
DebtDebt to Assets
49.9%
12.8x
Debt to EBITDAFree Cash Flow
$323m
-42.2%
1y CAGR+8.4%
3y CAGR-9.3%
5y CAGRNo items found.
Press Releases
Statements and updates from the company